Epidemiological aspects of allergic conjunctivitis
D Miyazaki, K Fukagawa, S Okamoto… - Allergology …, 2020 - jstage.jst.go.jp
abstract The prevalence of ocular allergies has been increasing worldwide for the past
several decades. The geographical distribution and hot spots of rhinoconjunctivitis have …
several decades. The geographical distribution and hot spots of rhinoconjunctivitis have …
Japanese guidelines for allergic conjunctival diseases 2017
E Takamura, E Uchio, N Ebihara, S Ohno… - Allergology …, 2017 - jstage.jst.go.jp
abstract The definition, classification, pathogenesis, test methods, clinical findings, criteria
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
Japanese guideline for allergic conjunctival diseases
E Takamura, E Uchio, N Ebihara, S Ohno… - Allergology …, 2011 - jstage.jst.go.jp
The definition, classification, pathogenesis, test methods, clinical findings, criteria for
diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway
S Sakamoto, K Aoki, T Higuchi, H Todaka… - … and cellular biology, 2009 - Taylor & Francis
The positive regulatory machinery in the microRNA (miRNA) processing pathway is
relatively well characterized, but negative regulation of the pathway is largely unknown …
relatively well characterized, but negative regulation of the pathway is largely unknown …
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis
Y Ohashi, N Ebihara, H Fujishima… - Journal of ocular …, 2010 - liebertpub.com
Aims: To examine the efficacy of tacrolimus ophthalmic suspension 0.1% in treating severe
allergic conjunctivitis. Methods: This was a multicenter, randomized, double-masked …
allergic conjunctivitis. Methods: This was a multicenter, randomized, double-masked …
One‐year clinical evaluation of 0.4% ripasudil (K‐115) in patients with open‐angle glaucoma and ocular hypertension
H Tanihara, T Inoue, T Yamamoto… - Acta …, 2016 - Wiley Online Library
Purpose To investigate the intra‐ocular pressure (IOP)‐lowering effects and safety of 0.4%
ripasudil (K‐115), a Rho kinase inhibitor, twice daily for 52 weeks, in patients with open …
ripasudil (K‐115), a Rho kinase inhibitor, twice daily for 52 weeks, in patients with open …
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement
A Fukushima, Y Ohashi, N Ebihara, E Uchio… - British Journal of …, 2014 - bjo.bmj.com
Background The objective of this study was to investigate the efficacy of topical 0.1%
tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal …
tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal …
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis
N Ebihara, Y Ohashi, E Uchio, S Okamoto… - Journal of ocular …, 2009 - liebertpub.com
Purpose: To evaluate the effectiveness and safety of a novel cyclosporine 0.1% aqueous
ophthalmic solution in a large population with vernal keratoconjunctivitis (VKC) and atopic …
ophthalmic solution in a large population with vernal keratoconjunctivitis (VKC) and atopic …
[HTML][HTML] Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
K Fukuda, W Ishida, J Uchiyama, M Rashel, S Kato… - 2012 - journals.plos.org
The therapeutic effects of bacteriophage (phage) KPP12 in Pseudomonas aeruginosa
keratitis were investigated in mice. Morphological analysis showed that phage KPP12 is a …
keratitis were investigated in mice. Morphological analysis showed that phage KPP12 is a …
Japanese guidelines for allergic conjunctival diseases 2020
D Miyazaki, E Takamura, E Uchio, N Ebihara… - Allergology …, 2020 - jstage.jst.go.jp
abstract The definition, classification, pathogenesis, test methods, clinical findings, criteria
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …
for diagnosis, and therapies of allergic conjunctival disease are summarized based on the …